861 followers
@DrEricDing PARP14 is itself a drug target for allergic inflammation (see https://t.co/1tG0tIQusX). So if the NSP3 part of ORF1a mimics PARP14 more closely than before, this could indeed disrupt human signaling pathways in new ways. BTW: Notice that PARP14